NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for FUSE yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Revenue growth to improve from $1.88M in 2026-Q1 | A primary condition in FUSEMACHINES INC's published investment case. The stated target is >1.88 million USD next 4 quarters. | Under Pressure | revenue falls below $1.88M over next 4 quarters | Revenue: $1.845M FY2026-Q3; GAAP. Published target: >1.88 million USD next 4 quarters. Target period is not explicitly aligned with this observation. Nov 3, 20261,845,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 7–Nov 5 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is speculative growth, not an established compounder: FUSE is pursuing an Agentic AI platform while revenue remains very small and recent financial performance is weak. The three-to-six-month thesis is on watch, with low confidence and risk recently rising to high.
FUSE is described as cheap versus peers, but confidence in that valuation assessment is low. The evidence does not specify what growth or execution expectations the market already assumes, so the expectations gap is unclear.
In the near term, management's AI focus has mixed evidence: revenue edged down from the first to the second quarter of 2026 while gross profit was slightly higher. Financing activity is on track, but repeated Nasdaq notices and recent increases in market risk add uncertainty; the evidence for a steadier multi-year financial trajectory is thin.
The next guidance update is a key near-term swing factor, as a cut could deepen concern about execution. Over the multi-year view, the thesis depends on AI platform commercialization translating into stronger business results and on listing compliance risks being addressed; lower rates or steadier large technology peers could also improve the sector backdrop.
FUSE remains a fragile, loss-making growth story with mixed execution and low-confidence valuation evidence. Its 1-to-3-year thesis hinges on better commercialization and progress on compliance, while near-term risks remain high. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Avoid Nasdaq delisting and maintain listing standards |
| A supporting condition in FUSEMACHINES INC's published investment case. The stated target is No delisting notices or failures to meet Nasdaq rules next 4 quarters. |
| Under Pressure |
| receives new Nasdaq delisting notices or fails listing rules |
2 active delisting notices vs 0 target Nasdaq issued notices on Sept 18 and Sept 25 for bid price and MVLS failures; stock at $0.28. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Reduce operating loss from -$3.04M in 2026-Q1 | A primary condition in FUSEMACHINES INC's published investment case. The stated target is operating loss > -3.04 million USD next 4 quarters. | Broken | operating loss worsens beyond -$3.04M over next 4 quarters | Operating income: $-2.314M FY2026-Q3; GAAP. Published target: operating loss > -3.04 million USD next 4 quarters. Target period is not explicitly aligned with this observation. Nov 3, 2026-2,314,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.